ebolavirus
singlestrand
negativesens
envelop
virus
belong
filovirida
famili
five
speci
known
four
caus
hemorrhag
fever
human
includ
ebola
viru
ebov
speci
respons
deadliest
epidem
death
outbreak
western
africa
antivir
drug
approv
understand
biolog
viru
essenti
develop
specif
treatment
ebov
enter
host
cell
bind
attach
factor
lectin
timtam
famili
member
interact
respect
viral
glycoprotein
gp
phospholipid
viral
envelop
gp
class
fusion
protein
present
surfac
virion
trimer
heterodim
compris
two
subunit
link
disulfid
bond
highli
glycosyl
receptorbind
subunit
fusion
subunit
intern
macropinocytot
pathway
cleav
low
ph
endosom
cysteineproteas
name
cathepsin
b
l
remov
mucin
domain
glycan
cap
produc
cleav
form
kda
bind
intracellular
receptor
niemannpick
cholesterol
transport
locat
late
endosomeslysosom
util
intracellular
viral
receptor
fairli
new
concept
virolog
known
filovirus
employ
arenaviru
lassa
viru
lasv
use
thought
rais
phthreshold
fusion
exact
role
ebov
entri
yet
determin
postul
bind
cathepsincleav
gp
gpcl
undergo
conform
chang
empow
mediat
fusion
factor
need
trigger
fusion
activ
gpcl
remain
debat
earli
work
show
host
cell
entri
mediat
gpcl
remain
sensit
lysosomotrop
agent
cystein
proteas
inhibitor
find
suggest
gpcl
requir
low
ph
addit
activ
inhibit
perhap
addit
cathepsin
cleavag
trigger
fusion
abil
addit
cell
biolog
biochem
studi
support
concept
furthermor
find
state
suggest
low
ph
engag
cloop
bind
domain
gpcl
within
suffici
trigger
fusion
endosom
two
pore
calcium
channel
subsequ
identifi
late
entri
factor
ebov
exact
role
fusion
known
contrast
literatur
cite
suggest
need
low
ph
addit
factor
support
gpclmediat
fusion
markosyan
et
al
propos
bind
suffici
induc
gpcl
induc
fusion
even
neutral
ph
present
studi
revisit
question
cleav
form
ebov
gp
gpcl
trigger
fusion
test
role
low
ph
potenti
trigger
factor
assay
employ
includ
highli
sensit
luciferasebas
cellcel
pseudoviruscel
fusion
assay
well
flow
cytometricbas
assay
cellcel
hemifus
find
suggest
neither
fulllength
suffici
trigger
signific
fusion
ph
test
even
presenc
addit
factor
includ
reduc
agent
neg
charg
lipid
abund
late
endosomeslysosom
cathepsin
cation
ca
k
elicit
detect
fusion
taken
togeth
result
suggest
cathepsin
prime
ebovgp
requir
one
factor
addit
low
ph
mediat
fusion
reaction
suffici
robust
allow
entri
ebov
genom
cytoplasm
initi
replic
dulbecco
modifi
eagl
medium
dmem
phenolr
free
dmem
trypsinedta
phenolr
free
trypsinedta
hank
balanc
salt
solut
hbss
sodium
pyruv
antibioticantimycot
ezlink
sulfonhslcbiotin
dii
dio
thermofish
scientif
phosphatebuff
salin
pb
corn
cosmic
calf
serum
cc
supplement
calf
serum
sc
fetal
bovin
serum
fb
hyclon
fibronectin
millipor
polyethylenimin
pei
nonenzymat
cell
dissoci
solut
sigma
thermolysin
vitacyt
lipofectamin
invitrogen
zeocin
invivogen
cathepsin
b
athen
research
technolog
cathepsin
l
gift
dusan
turk
cathepsin
b
l
substrat
respect
calbiochem
bi
monoacylglycero
phosphat
r
isom
bmp
avanti
polar
lipid
delipid
bsa
gift
david
castl
univers
virginia
enduren
dualglo
luciferas
assay
system
promega
cell
obtain
atcc
via
univers
virginia
tissu
cultur
facil
cell
kind
gift
dougla
desimon
univers
virginia
kind
gift
jame
casanova
univers
virginia
cell
maintain
dmem
contain
cc
cell
maintain
dmem
contain
fb
sodium
pyruv
antibioticantimycot
cell
maintain
dmem
contain
sc
stabl
clone
express
full
length
cell
surfac
gener
follow
plasmid
origen
dna
encod
full
length
excis
plasmid
use
enzym
nhei
xhoi
clone
vector
thermofish
scientif
cut
enzym
use
standard
procedur
cell
seed
plate
day
transfect
empti
vector
neg
control
cell
line
transfect
assess
cell
viabil
follow
zeocin
exposur
use
lipofectamin
accord
manufactur
instruct
two
day
transfect
cell
replat
dish
incub
zeocin
complet
dmem
cell
passag
twice
zeocin
surviv
cell
maintain
complet
dmem
zeocin
form
coloni
coloni
individu
pick
transfer
well
well
plate
cell
expand
character
express
plasma
membran
cell
surfac
biotinyl
plasmid
mayinga
strain
kind
gift
paul
bate
univers
pennsylvania
pfurin
plasmid
kind
gift
gari
thoma
univers
pittsburgh
lymphocyt
choriomening
viru
lcmv
gp
plasmid
kind
gift
juan
de
la
torr
scripp
research
institut
la
jolla
ca
vsvg
plasmid
kind
gift
michael
whitt
univers
tennesse
plasmid
encod
solubl
membran
bound
pdisplay
vector
prepar
jame
simmon
accord
publish
procedur
firefli
plasmid
addgen
dual
split
plasmid
kind
gift
naoyuki
kondo
monoclon
antibodi
kind
gift
carolyn
wilson
food
drug
administr
rabbit
tubulin
sigma
aldrich
monoclon
abcam
antibeta
tubulin
mous
monoclon
antibodi
sigma
aldrich
streptavidin
magnet
sepharos
bead
ge
healthcar
antibodi
licor
mous
antibodi
gift
michael
whitt
cell
western
perform
essenti
describ
cell
express
ebov
gpcl
kda
vsv
pseudovirus
prepar
describ
cell
seed
fibronectin
coat
well
cellswel
well
plate
grown
overnight
cloop
bind
ebov
gpcl
cell
solubl
cloop
prepar
describ
ad
per
well
vsv
pseudoviru
bind
pseudovirus
ad
per
well
cell
centrifug
transfer
ice
wash
cold
pb
fix
paraformaldehyd
min
rt
permeabil
wash
trition
pb
min
per
wash
block
h
rt
licor
odyssey
block
buffer
primari
antibodi
ha
block
buffer
ad
cell
incub
overnight
wash
time
pb
plu
min
per
wash
secondari
antibodi
block
buffer
ad
plate
incub
h
rt
wash
time
pb
pb
minwash
dri
plate
scan
licor
odyssey
clx
nearinfrar
imag
system
red
green
intens
per
well
determin
measur
function
imagej
ratio
ha
gapdh
vsvm
gapdh
calcul
averag
assay
perform
previous
describ
briefli
use
gener
transfect
effector
cell
express
lcmvgp
viral
glycoprotein
nogp
well
target
cell
express
fulllength
addit
plasmid
encod
furin
transfect
alongsid
ebovgp
plasmid
gener
form
cell
surfac
two
day
transfect
effector
cell
load
enduren
cocultur
target
cell
ph
puls
appli
min
unless
otherwis
state
hm
fusion
buffer
mm
nacl
mm
hepe
mm
succin
mm
me
glucos
adjust
appropri
ph
addit
compon
indic
medium
replac
luciferas
activ
measur
h
ph
puls
cellcel
fusion
assay
assess
effect
exogen
cathepsin
b
l
cathepsin
preactiv
preactiv
buffer
sodium
acet
edta
ph
contain
fresh
dtt
min
preactiv
cathepsin
dilut
hm
fusion
buffer
indic
ph
incub
rt
min
preactiv
cathepsin
hm
fusion
buffer
indic
ph
use
immedi
ie
immedi
ad
cell
min
ph
reneutr
cell
process
describ
gener
cellcel
fusion
assay
assess
cathepsin
activ
preactiv
cathepsin
dilut
hm
fusion
buffer
ph
without
cystein
proteas
inhibitor
cathepsin
b
inhibitor
incub
rt
min
cathepsin
b
l
substrat
ad
ratio
preactiv
cathepsin
mixtur
incub
min
fluoresc
exem
measur
use
biotek
synergi
ht
plate
reader
cellcel
fusion
assay
assess
effect
ad
bmp
plasma
membran
cocultur
cell
chill
min
wash
cold
pb
next
mixtur
bmp
delipid
bsa
ad
cell
serum
free
dmem
min
immedi
cell
rins
pb
subject
ph
puls
cell
process
gener
cellcel
fusion
assay
cell
seed
plate
x
cellswel
next
day
gener
effector
cell
express
lcmv
gp
viral
glycoprotein
gp
cell
transfect
glycoprotein
plasmid
addit
furin
plasmid
transfect
alongsid
ebovgp
plasmid
gener
form
cell
surfac
gener
target
cell
express
express
cell
transfect
membraneanchor
plasmid
cell
transfect
use
lipofectamin
accord
manufactur
instruct
twentyfour
hour
posttransfect
effector
target
cell
stain
dio
dii
respect
min
complet
dmem
cell
rins
pb
lift
nonenzymat
celldissoci
solut
cell
pellet
resuspend
complet
phenolr
free
dmem
effector
cell
cocultur
target
cell
fibronectin
coat
plate
h
ph
puls
appli
hm
fusion
buffer
adjust
appropri
ph
min
ph
reneutr
replac
buffer
complet
dmem
cell
return
h
cell
lift
phenol
redfre
trypsin
fix
pfa
analyz
bd
facscalibur
data
analyz
flowjo
plot
use
fc
express
protocol
produc
vsv
pseudovirus
encod
renilla
luciferas
describ
previous
briefli
cell
cm
dish
transfect
plasmid
encod
ebovflgp
lcmvgp
addit
plasmid
encod
furin
transfect
alongsid
cell
transfect
allow
express
cleav
form
gp
surfac
particl
next
day
cell
infect
helper
viru
encod
renilla
luciferas
supernat
contain
pseudovirus
harvest
pellet
sucros
cushion
resuspend
steril
solut
sucros
hm
buffer
mm
nacl
mm
hepe
mm
me
ph
twentyf
microgram
ebovflgp
vsv
pseudovirus
cleav
form
gp
mgml
freshli
prepar
thermolysin
presenc
mm
virus
incub
min
reaction
quench
ad
phosphoramidon
assay
describ
previous
briefli
cell
transfect
express
membraneanchor
firefli
luciferas
two
day
cell
chill
ice
min
incub
lcmvgp
vsvluciferas
renilla
pseudovirus
least
well
per
sampl
bind
cold
ph
puls
appli
min
hm
buffer
adjust
indic
ph
valu
buffer
replac
dmem
contain
mm
twentyfour
hour
later
luciferas
activ
measur
use
dualglo
luciferas
assay
system
promega
viral
fusion
plasma
membran
assess
ratio
renilla
luciferas
activ
indic
viru
replic
firefli
luciferas
activ
account
number
cell
cell
analyz
cellsurfac
biotinyl
seed
plate
cell
chill
ice
min
rins
three
time
cold
hbss
cell
incub
min
ice
mgml
ezlink
sulfonhslcbiotin
dilut
hbss
cell
wash
three
time
pb
bsa
mm
glycin
ph
lyse
triton
lysat
precipit
use
streptavidin
magnet
sepharos
bead
accord
manufactur
instruct
bead
boil
sdspage
sampl
buffer
collect
magnet
elut
fraction
analyz
blot
sdspage
gel
indic
protein
work
vsv
pseudovirus
encod
lcmv
ebov
gp
primat
cell
perform
biosafeti
level
accord
review
approv
institut
biosafeti
committe
univers
virginia
school
medicin
intracellular
receptor
ebov
luminallyori
cloop
suffici
bind
cathepsinprim
ebovgp
suffici
cloop
bind
cleav
ebov
gp
gpcl
mediat
entri
endosom
demonstr
use
domain
construct
delet
mutant
chimera
niemannpick
like
paralog
latter
studi
address
suffici
cloop
fusion
per
se
therefor
first
ask
whether
cloop
low
ph
suffici
drive
fusion
activ
gpcl
first
explor
suffici
cloop
low
ph
use
highli
sensit
cellcel
fusion
ccf
assay
assay
effector
cell
express
gpcl
fig
cocultur
target
cell
express
cloop
cell
surfac
fig
effector
cell
avoid
toxic
thermolysin
treatment
cell
express
fulllength
ebovgp
gener
kda
gp
coexpress
dna
encod
ebov
gp
furin
cleavag
site
posit
furin
yield
kda
gp
form
capabl
bind
cloop
also
see
fig
effector
target
cell
addit
express
one
half
split
luciferasesplit
gfp
construct
respect
fusion
occur
result
syncytia
express
luciferas
gfp
effector
cell
express
gp
lymphocyt
choriomening
viru
lcmv
use
posit
control
seen
fig
panel
puls
ph
cellcel
fusion
content
mix
observ
cell
express
target
cell
either
express
cloop
surfac
observ
luciferas
activ
level
compar
seen
effector
cell
harbor
gp
contrast
robust
luciferas
signal
indic
ccf
observ
cell
express
lcmvgp
ph
target
cell
express
cloop
fig
consist
ph
requir
lcmv
gpmediat
fusion
suggest
low
ph
suffici
trigger
ebovgpcl
mediat
ccf
lead
content
mix
second
test
suffici
cloop
low
ph
ebovgpcl
fusion
next
conduct
sensit
forc
fusion
plasma
membran
ffpm
experi
fig
vsv
pseudovirus
encod
renilla
luciferas
express
gpcl
fig
bound
target
cell
express
cloop
surfac
fig
cell
bound
pseudovirus
briefli
puls
ph
cultur
h
assay
renilla
luciferas
readout
fusion
entri
infect
bind
conduct
prevent
pseudoviru
intern
ph
puls
cell
maintain
lysosomotrop
weak
base
rais
endosom
ph
prevent
fusion
might
occur
normal
endocyt
rout
test
use
vsv
pseudovirus
express
kda
ebov
gp
gener
thermolysin
cleavag
pseudovirus
express
fulllength
gp
well
one
bear
kda
ebov
gp
gener
furin
site
mutant
describ
fig
control
show
infecti
level
kda
kda
ebov
gp
lcmv
gp
pseudovirus
use
similar
similarli
inhibit
pseudovirus
allow
enter
cell
via
normal
endocyt
rout
fig
seen
fig
wherea
ampl
ffpm
seen
pseudovirus
bear
lcmv
gp
fusion
signal
background
observ
vsv
pseudovirus
bear
either
form
ebovgpcl
ph
test
ccf
ffpm
assay
employ
fig
monitor
content
mix
report
plasmid
gener
luciferas
signal
result
fuse
cell
sinc
find
present
thu
far
suggest
cloop
low
ph
suffici
ebovgpcl
mediat
complet
fusion
lead
content
mix
next
ask
whether
suffici
mediat
earlier
stage
hemifus
use
lipid
mix
assay
employ
markosyan
et
al
effector
cell
express
ebovgpcl
label
fluoresc
lipid
probe
dio
mix
target
cell
express
cloop
label
fluoresc
lipid
probe
dii
cocultur
exposur
differ
ph
buffer
cell
analyz
hemifus
effector
target
cell
flow
cytometri
analysi
cell
popul
undergon
lipid
mix
distinguish
unfus
cell
pair
higher
dii
intens
hemi
fuse
cell
due
fluoresc
reson
energi
transfer
dio
dii
lead
enhanc
dii
fluoresc
cell
undergo
lipid
mix
fig
seen
fig
wherea
lipid
mix
signal
detect
effector
cell
express
lcmv
gp
treat
ph
hemifus
signal
background
detect
effector
cell
express
ebovgpcl
whether
target
cell
express
cloop
surfac
although
cell
express
ebovgpcl
show
appar
increas
bind
cell
express
cloop
compar
one
express
cloop
surfac
fig
result
present
fig
suggest
cloop
low
ph
suffici
trigger
fusion
activ
ebovgpcl
therefor
test
whether
five
addit
factor
could
evok
full
fusion
content
mix
activ
test
fig
employ
sensit
split
luciferas
ccf
assay
experi
includ
effector
cell
express
lcmv
gp
posit
control
ccf
first
test
whether
elev
temperatur
could
promot
fusion
sinc
high
temperatur
substitut
physiolog
trigger
prompt
conform
chang
fusion
virus
influenza
elev
temperatur
also
induc
ebov
gpcl
ectodomain
bind
liposom
low
ph
howev
temperatur
high
fail
induc
gpcl
mediat
ccf
target
cell
express
cloop
ph
test
fig
next
assess
effect
reduc
agent
tcep
sinc
reductas
present
late
endosomeslysosom
sinc
mm
tcep
caus
ectodomain
ebovgpcl
bind
liposom
activ
diminish
fusion
loop
mutant
howev
seen
fig
ccf
background
seen
effector
cell
express
ebovgpcl
presenc
mm
tcep
ph
test
elev
temperatur
reduc
agent
appear
suffici
induc
isol
gpcl
ectodomain
bind
liposom
suffici
induc
full
fusion
support
notion
addit
factor
requir
third
addit
factor
test
cation
specif
ca
k
ebov
entri
requir
endosom
calcium
channel
glycoprotein
rubella
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
syndrom
coronaviru
merscov
report
requir
ca
optim
function
k
need
product
entri
influenza
bunyavirus
howev
test
use
split
luciferas
ccf
assay
presenc
absenc
either
cation
concentr
test
induc
ebovgpcl
mediat
cellcel
fusion
signal
background
ph
test
fig
similar
result
found
use
ffpm
assay
fig
fourth
addit
factor
test
whether
addit
cathepsin
b
l
could
evok
fusion
activ
ebov
gpcl
experi
motiv
find
cystein
proteas
inhibitor
inhibit
entri
kda
ebov
gp
howev
seen
fig
applic
preactiv
cathepsin
b
l
fig
induc
ebov
gpcl
mediat
ccf
background
level
ph
test
last
addit
factor
test
anion
lipid
bi
monoacylglycero
phosphat
bmp
lipid
enrich
late
endosom
lysosom
requir
fusion
entri
dengu
uukuniemi
virus
howev
seen
fig
ad
bmp
unleash
detect
fusion
activ
ebov
gpcl
collect
result
present
fig
suggest
cloop
low
ph
suffici
induc
ebovgpcl
mediat
detect
fusion
even
system
supplement
elev
temperatur
reduc
agent
ca
k
exogen
cathepsin
b
l
anion
lipid
bmp
suffici
bind
ebovgpcl
promot
entri
infect
endosom
howev
domain
could
need
trigger
optim
ebov
gpclmediat
fusion
inde
miller
et
al
show
could
rescu
entri
infect
cell
rescu
stronger
knockout
cell
complement
full
length
also
show
reciproc
construct
lack
cloop
strongli
impair
entri
infect
construct
lack
domain
also
impair
albeit
less
strongli
addit
gong
et
al
report
affin
gpcl
higher
full
length
isol
cloop
therefor
ask
fulllength
could
induc
fusion
activ
ebovgpcl
mainli
found
late
endosom
cell
may
express
endogen
surfac
fig
gel
untransfect
target
cell
control
c
target
cell
clone
also
see
first
set
experi
transient
overexpress
transfect
target
cell
plasmid
encod
full
length
cdna
control
cmv
promot
condit
substanti
amount
found
cell
surfac
detect
cell
surfac
biotinyl
fig
gel
transfect
target
cell
cell
transient
express
full
length
surfac
test
target
split
luciferas
ccf
assay
effector
cell
express
ebovgpcl
surfac
fig
gel
effector
cell
describ
howev
cloop
fulllength
elicit
detect
content
mix
ccf
activ
ebovgpcl
ph
test
lcmvgp
induc
robust
ccf
low
ph
fig
test
gener
stabl
clone
cell
express
signific
level
surfac
fig
gel
clone
consist
find
transient
transfect
cell
fig
gpclmediat
fusion
detect
target
cell
stabli
express
full
length
surfac
fig
lastli
ask
whether
three
potenti
physiolog
relev
addit
factor
conjunct
full
length
low
ph
could
evok
detect
ccf
activ
ebovgpcl
howev
addit
cation
ca
k
fig
exogen
cathepsin
b
cat
l
fig
fig
anion
lipid
bmp
fig
promot
detect
ebovgpclmedi
ccf
target
cell
stabli
express
full
length
surfac
ebola
viru
ebov
highli
lethal
envelop
viru
employ
unusu
complex
pathway
enter
host
cell
engag
attach
factor
cell
surfac
differ
differ
cell
ebov
particl
engulf
macropinocytosi
traffick
via
earli
late
endosom
endocyt
compart
refer
late
endosomelysosom
leli
en
rout
receptor
bind
subunit
ebov
glycoprotein
gp
cleav
cathepsin
b
l
gener
cleav
kda
speci
bind
cloop
ebov
endosom
receptor
fusion
ensu
acid
leli
envelop
virus
enter
cell
endosom
even
lassa
viru
second
viru
shown
use
intracellularendosom
receptor
low
ph
suffici
trigger
conform
chang
elicit
fusion
activ
viral
fusion
gp
fusion
gp
sar
mer
coronavirus
addit
requir
post
receptor
bind
endosom
proteolyt
cleavag
event
condit
elicit
fusion
activ
cathepsincleav
ebov
gp
gpcl
debat
find
state
miller
et
al
indic
low
ph
trigger
recombin
vsv
particl
bear
ebov
gpcl
kda
form
gener
thermolysin
cleavag
fuse
therebi
infect
cell
express
surfac
markosyan
et
al
report
cell
surfac
suffici
mediat
cellcel
fusion
ccf
cell
express
ebov
gpcl
see
conflict
conclus
reexamin
suffici
trigger
fusion
activ
ebov
gpcl
process
also
assess
potenti
enhanc
role
addit
factor
shown
outlin
result
section
augment
fusion
endocytos
envelop
virus
find
consist
extend
result
state
miller
et
al
found
cell
express
either
full
length
surfac
serv
adequ
target
detect
fusion
ph
test
effector
cell
pseudoviru
particl
bear
ebov
gpcl
kda
kda
form
moreov
appar
insuffici
seen
even
effectortarget
cell
pair
addit
expos
elev
temperatur
reduc
agent
ca
k
anion
lipid
bmp
cathepsin
b
l
markosyan
et
al
monitor
ccf
effector
cell
bear
ebov
gpcl
either
kda
kda
form
target
cell
bear
score
mix
fluoresc
lipid
dye
well
small
dalton
aqueou
content
dye
also
queri
electr
conduct
effectortarget
cell
pair
expos
ph
conclud
small
nonexpand
fusion
pore
form
neutral
quickli
low
ph
optim
ph
employ
deliveri
express
luciferas
report
plasmid
differ
highli
sensit
content
mix
assay
use
lipid
mix
assay
markosyan
et
al
per
gomezicazbalceta
et
al
gate
bound
adher
unfus
cell
pair
fig
mean
analysi
observ
detect
lipid
mix
signal
effector
cell
bear
ebov
gpcl
ph
test
lipid
mix
detect
effector
cell
bear
lcmv
gp
ph
dispar
lipid
mix
result
could
due
technic
analyt
differ
irrespect
small
nonexpand
fusion
pore
report
markosyan
et
al
would
like
lead
product
viral
infect
small
pass
viral
nucleocapsid
henc
conclud
low
ph
suffici
drive
fusion
activ
ebov
gpcl
conclus
consist
xray
analysi
complex
indic
small
like
import
conform
chang
occur
ebov
gpcl
bind
ph
albeit
seen
crystal
form
exampl
evid
bind
ebov
gpcl
low
ph
caus
expuls
fusion
loop
bodi
gpcl
trimer
base
find
state
miller
et
al
present
fig
postul
factor
addit
low
ph
need
elicit
fusion
activ
ebov
gpcl
therefor
test
factor
requir
fusion
uncoat
endocytos
envelop
virus
ca
k
bmp
proteas
propos
ebov
particular
ca
addit
cathepsin
action
reduc
agent
even
nonphysiolog
condit
elev
temperatur
substitut
biolog
viral
fusion
trigger
howev
none
factor
treatment
elicit
detect
ccf
effector
cell
bear
ebov
gpcl
target
cell
bear
cloop
ph
test
robust
ccf
consist
detect
effector
cell
bear
lcmv
gp
low
ph
although
rule
one
test
addit
factor
induc
hemifus
small
nonexpand
fusion
pore
ccf
would
observ
combin
factor
favor
hypothesi
fusion
activ
ebov
gpcl
requir
low
ph
yet
identifi
like
endosom
factor
initi
observ
indic
need
addit
factor
pseudoviru
particl
bear
kda
ebov
gp
infecti
target
cell
pretreat
lysosomotrop
agent
rais
endosom
ph
cystein
proteas
inhibitor
find
confirm
other
context
interest
spenc
et
al
recent
found
live
cell
imag
studi
employ
vsv
particl
bear
ebov
gpcl
step
follow
hemifus
ie
stage
fusion
pore
format
particl
uncoat
hand
observ
fusion
isol
ebov
fusion
loop
ebov
reconstitut
proteoliposom
liposom
low
ph
suggest
major
role
addit
factor
may
move
suffici
way
proceed
along
fusion
pathway
addit
caveat
inabl
detect
fusion
signal
ebov
gpcl
condit
test
one
densiti
cloop
surfac
target
cell
employ
may
high
enough
conjunct
low
ph
trigger
fusion
secondli
although
test
ad
lelysabund
lipid
bmp
need
full
fusion
dengu
uukuniemi
virus
plasma
membran
lipid
composit
may
support
ebov
gpclmediat
fusion
design
occur
leli
plasma
membran
leli
membran
differ
lipid
composit
plasma
membran
may
contain
lipid
protein
factor
inhibitori
ebov
gpclmediat
fusion
anoth
possibl
addit
leli
membran
protein
exampl
requir
membran
protein
mediat
ca
efflux
leli
cell
lack
strongli
impair
ebov
infect
perhap
need
maintain
precis
local
concentr
ca
mimick
experi
ca
could
need
stabil
structur
fusion
loop
fusion
loop
interact
leli
lipid
bilay
lastli
anoth
membran
protein
leli
specif
solubl
compon
present
lumen
leli
ion
small
molecul
protein
could
requir
ebov
gpcl
mediat
robust
fusion
inde
multipl
factor
could
need
maintain
precis
ionic
milieu
endosom
lumen
need
support
ebov
fusion
context
potenti
interest
lipid
ion
transport
protein
emerg
recent
crispr
screen
host
factor
requir
ebov
infect
conclus
studi
highlight
complex
ebov
fusion
mechan
add
support
propos
addit
cue
necessari
cleavag
gp
gpcl
bind
exposur
low
ph
ebov
open
expand
sustain
robust
fusion
pore
futur
studi
aim
identifi
put
miss
factor
test
filovir
gp
may
prone
fusion
suggest
recent
report
rueda
et
al
